Adaptimmune Therapeutics
Earnings Date & Report
Last updated:
Adaptimmune Therapeutics’s last earnings date was on 4 Mar 2024.
Adaptimmune Therapeutics stock Earnings report, Estimates & History
| 2019-05-06 | -0.21598 | -0.26 |
|---|---|---|
| 2019-08-01 | -0.45813 | -0.39 |
| 2019-11-06 | -0.42422 | -0.36 |
| 2020-02-27 | -0.26445 | -0.3 |
| 2020-05-14 | -0.22738 | -0.24 |
| 2020-08-06 | -0.24475 | -0.24 |
| 2020-11-05 | -0.22678 | -0.24 |
| 2021-02-25 | -0.24792 | -0.24 |
| 2021-05-06 | -0.2304 | -0.24 |
| 2021-08-09 | -0.2353 | -0.24 |
| 2021-11-04 | -0.33963 | -0.3 |
| 2022-03-14 | -0.89143 | -0.24 |
| 2022-05-09 | -0.41034 | -0.3 |
| 2022-08-04 | -0.31979 | -0.28 |
| 2022-11-08 | -0.24 | -0.24 |
| 2023-03-06 | -0.13046 | -0.18 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Adaptimmune Therapeutics stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 4 Mar 2024 | N/A | N/A | N/A | N/A | N/A | |
| 2 Aug 2023 | N/A | N/A | N/A | N/A | N/A | |
| 12 May 2023 | N/A | -$0.14 | N/A | 4.93M | N/A | Earnings Call Transcript |
| 6 Mar 2023 | Missed | -$0.13 | -$0.18 | 4.93M | 11.02M | Earnings Call Transcript |
| 31 Dec 2022 | N/A | N/A | -$0.03 | N/A | 11.02M | |
| 8 Nov 2022 | Matched | -$0.24 | -$0.24 | N/A | 7.00M | Earnings Call Transcript |
| 4 Aug 2022 | Beat | -$0.32 | -$0.28 | N/A | 7.00M | |
| 9 May 2022 | Beat | -$0.41 | -$0.3 | 3.41M | 5.53M | Earnings Call Transcript |
| 14 Mar 2022 | Beat | -$0.89 | -$0.24 | 77.76M | 3.57M | Earnings Call Transcript |
| 4 Nov 2021 | Beat | -$0.34 | -$0.3 | 1.37M | 1.41M | Earnings Call Transcript |
| 9 Aug 2021 | Missed | -$0.24 | -$0.24 | 3.09M | 1.20M | Earnings Call Transcript |
| 6 May 2021 | Missed | -$0.23 | -$0.24 | 451.36K | 3.09M | Earnings Call Transcript |
| 25 Feb 2021 | Beat | -$0.25 | -$0.24 | 1.98M | 434K | Earnings Call Transcript |
| 5 Nov 2020 | Missed | -$0.23 | -$0.24 | 1.24M | 1.50M | |
| 6 Aug 2020 | Beat | -$0.24 | -$0.24 | 481.08K | 1.19M | |
| 14 May 2020 | Missed | -$0.23 | -$0.24 | 792.70K | 502K | Earnings Call Transcript |
| 27 Feb 2020 | Missed | -$0.26 | -$0.3 | 825.06K | 761K | Earnings Call Transcript |
| 6 Nov 2019 | Beat | -$0.42 | -$0.36 | 204.08K | 728K | |
| 1 Aug 2019 | Beat | -$0.46 | -$0.39 | 132.84K | 237K | |
| 6 May 2019 | Missed | -$0.22 | -$0.26 | N/A | 157K | |
Adaptimmune Therapeutics Earnings report FAQs
When is Adaptimmune Therapeutics's next Earnings date?
The company has not set the next earnings date yet. The latest Adaptimmune Therapeutics's earnings date was on 31 Dec 2022.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.